SCHEMBL395191

SCHEMBL395191

COCCNC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL395610 0.98
Sulfuric Acid SCHEMBL11559579 0.89 ALOX15 (0.49)
SCHEMBL4094463 0.87 MEN1 (0.38)
SCHEMBL6938635 0.87 MEN1 (0.38)
SCHEMBL1427269 0.86
SCHEMBL6936352 0.84 SMN1; SMN2 (0.47)
SCHEMBL1345487 0.83 MEN1 (0.39)
Trifluoroacetic Acid SCHEMBL5775856 0.83 HPGD (0.37)
SCHEMBL4093658 0.82 DDAH1 (0.40)
SCHEMBL6935672 0.82 MEN1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101744-B2 Isolation and purification of nucleic acids with a solid phase ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2012-01-24 US claimed
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine MALLE GERARD 2009-08-06 US claimed
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE L'OREAL S.A. 2009-06-04 US claimed
US-20080319182-A1 ISOLATION AND PURIFICATION OF NUCLEIC ACIDS WITH A SOLID PHASE ROCHE DIAGNOSTICS GMBH (DE) 2008-12-25 US claimed
EP-1983051-A2 Isolation and purification of nucleic acid molecules with solid phase Roche Diagnostics GmbH (DE) 2008-10-22 EP claimed
CN-101289661-A Isolation and purification of nucleic acid molecules with solid phase HOFFMANN LA ROCHE (CH) 2008-10-22 CN claimed
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin L'OREAL S.A. (FR) 2005-06-23 US claimed
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine L'OREAL 2005-06-16 US claimed
EP-1532963-A1 Composition for straightening the hair comprising at least one imine not being an hydroxide L'OREAL (FR) 2005-05-25 EP claimed
EP-1532960-A1 Hair styling composition containing a non-hydroxide imine L'OREAL (FR) 2005-05-25 EP claimed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP claimed
EP-0401010-A2 Pyranyl cyanoguanidine derivatives E.R. Squibb &amp; Sons, Inc. (US) 1990-12-05 EP claimed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP claimed
US-20250340530-A1 GCN2 INHIBITOR (as amended) IP2IPO INNOVATIONS LTD (GB) 2025-11-06 US disclosed
EP-4522610-A1 GCN2 INHIBITORR IP2IPO Innovations Limited (GB) 2025-03-19 EP disclosed
CN-119451955-A GCN2 inhibitors IP2IPO创新有限公司 2025-02-14 CN disclosed
US-5223498-A Hypoglycemic agents THE BOOTS COMPANY PLC (GB) 1993-06-29 US disclosed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP disclosed
CN-1057648-A Therapeutical agent BOOTS CO PLC (GB) 1992-01-08 CN disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP disclosed